Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5539_Библиотеки_им_академика_М_И_Перельмана.pdf
INDEX
A
Acetylcholinesterase (AChE) 267
Acetylcholinesterase enzyme (AChE) 268
allele-specic amplication (ASA) 57
Allele-specic oligonucleotide (ASO)
hybridization 2
Alzheimer’s disease 267, 268, 270, 272,
273
American Society for Clinical Pathology
(ASCP) 116
American Society of Clinical Oncology
(ASCO) 115
Amplication Refractory Mutation Sys-
tem 2
amplication refractory mutation system
(ARMS) 57
antibody binding capacity (ABC) 234,
235
antiretroviral (ARV) 234, 242
arrhythmic right ventricular cardiomyo-
pathy (ARVC) 81
ascitic uid 262
Association for Molecular Pathology
(AMP) 116
Autoimmune cardiomyopathy 87
avian inuenza viruses (AIVs) 170
B
Bacterial bloodstream infection (bBSI)
147, 148
Becton Dickinson (BD) 236
blood culture (BC) 148
Bloodstream infection (BSI) 148
breast cancer (BC) 24
Brucella 103, 104, 105, 106, 107, 108,
109, 111
Brucellosis 103, 104, 105, 276
278
Advances in Molecular Diagnostics
C
Ca125 261, 262, 263, 264, 278
cardiac dysfunction 81
cardiological laboratories 80
Cardiomyopathies 79
chemotherapy 251, 252
chromosomes 5, 9, 10, 14
circulating tumor cells (CTC) 52
clinical diagnosis 1
Clinical Laboratory Improvement
Amendments- (CLIA-) 123
College of American Pathologists (CAP)
116
Colorectal cancer (CRC) 113, 114
Colored immunospots 84
combination antiretroviral therapy
(cART) 235
competitive oligonucleotide priming
(COP) 57
comprehensive bio-analytical system
(COBAS) 239
continuous ow centrifugation (CFC)
201
conventional morphology 73, 74
Copy Number Variation (CNV) 23, 25
copy number variations (CNV) 60
C-reactive protein (CRP) 161
D
dierentiated thyroid carcinomas (DTCs)
220
dilated cardiomyopathy (DCM) 80
dot blot analysis 2
Drosophila melanogaster (DmAChE)
267, 268, 272
Ethylene di-amine tetra acetic acid
(EDTA) 236
European Society of Cardiology (ESC) 80
F
ne needle aspiration (FNA) 117
Fluorescent In-situ Hybridization 8
follicular thyroid carcinoma (FTC) 220
Food and Drug Administration (FDA)
23, 114
formalin-xed, paran-embedded
(FFPE) 24
Fungi 185, 187
G
gastrointestinal stromal tumor (GIST)
217
Gastrointestinal Stromal Tumor (GIST)
64
Genome Analysis Tool Kit (GATK) 60
GTP (Guanosine triphosphate) 222
H
Head and neck squamous cell carcinoma
(HNSCC) 251, 252
hemagglutinin (HA) 170
hepatitis B virus (HBV) 20
hepatocellular carcinoma (HCC) 20
highly active antiretroviral treatment
(HAART) 234
high performance liquid chromatography
(HPLC) 58
hormone receptor (HR) 24
Human Immunodeciency Virus (HIV)
233
E
endemic disease 103
endocrine malignancy 220
Endomyocardial Biopsy 6
endomyocardial biopsy (EMB) 81
enzyme-linked immunosorbent assay
(ELISA) 200
I
Illumina 52, 54, 55, 56, 61, 64, 65, 67
Immunoassays 6
immunouorescence assays (IFAs) 199
Immunohistochemical diagnostics 83
immunohistochemistry (IHC) 121
immunomagnetic separation (IMS) 201
Inammatory response 88
Index
279
inuenza surveillance 169, 171, 180
inuenza virus 172, 178, 180, 183
intensive care unit (ICU) 154
International Association for the Study of
Lung Cancer (IASLC) 116
irradiation therapy 251, 252, 254
K
Kenya Medical Research Institute
(KEMRI) 236
L
Light-Cycler-SeptiFast (LC-SF) 155
limit of detection (LOD) 52
Lipopolysaccharide-binding protein
(LBP) 161
M
medullary thyroid carcinomas (MTCs)
220
melanocytic tumors 73, 74, 75, 76
Melanoma 74
melanoma patients 73, 74
mesothelial cells 264
methylguanine DNA methyltransferase
(MGMT) 216
Microbial genomes 85
microsatellite instability (MSI) 124
microsatellite-stable (MSS) 124
Microsporidia 185, 186, 191, 199, 203,
204, 205, 206, 210, 213, 277
microsporidiosis 186, 187, 200, 202, 206,
207, 208, 210, 211, 212
mismatch amplication mutation assay
(MAMA) 57
molecular biology 216, 217
Molecular diagnostics 74
Multiplex Ligation-Dependent Probe
Amplication 5
mutant allele–specic amplication
(MASA) 57
mutations 1, 2, 3, 4, 5, 11
myocardium 79, 82, 90, 92, 93, 94
N
National Cancer Comprehensive Network
(NCCN) 116
National Center of Biotechnology Infor-
mation (NCBI) 172
neoplasia 217
neuraminidase (NA) 170
Next Generation Sequencing 5
Next generation sequencing (NGS) 21
Nosema bombycis 185
nucleic acid 103
Nucleic Acid Sequence Based Amplica-
tion (NASBA) 156
O
octamer-binding transcription factor 4
(Oct4) 254
oncogenesis 216
Orthomyxoviridae 170
P
pancreatic 219, 221
Papillary thyroid carcinoma (PTC) 220
papillary thyroidcarcinomas 219
PCR amplication of multiple specic
alleles (PAMSA) 57
PCR amplication of specic alleles
(PASA) 57
Personal Genome Machine (PGM) 55
polymerase chain reaction (PCR) 103
polymorphisms 1, 14, 15
polyserositis 262, 264
protein phosphatase 2A (PP2A) 253
R
reactive oxygen species (ROS) 223, 224
recurrent polyserositis 262, 263
RESTRICTION FRAGMENT LENGTH
POLYMORPHISM 2
reticuloendothelial system 104
280
Advances in Molecular Diagnostics
S
Single-Nucleotide Polymorphism Array
6
single nucleotide polymorphism (SNP)
92
single nucleotide polymorphisms (SNPs)
107
single-nucleotide polymorphisms (SNPs)
20
Solid Tumor Actionable Mutation Panel
(STAMP) 65
system inammatory respiratory syn-
drome (SIRS) 161
T
Tetraphenylporphinesulfonate (TPPS)
267, 272
yroid cancer 220, 229
transmission electron microscopy (TEM)
187
triple negative breast cancer (TNBC) 24
tumor radio tolerance 251
V
variants of unknown signicance (VUS)
26
virus subtype identication 171
vitamin D receptor (VDR) 20
